Literature DB >> 10337979

Microsurgical removal of a vestibular schwannoma after stereotactic radiosurgery: surgical and pathologic findings.

M Schulder1, G S Sreepada, J A Kwartler, E S Cho.   

Abstract

OBJECTIVE: The objective of this study was to provide objective evidence of the enhanced difficulty of preserving the facial nerve in patients who need microsurgery after failed stereotactic radiosurgery (SRS) of vestibular schwannoma. STUDY
DESIGN: This study was a retrospective case review.
SETTING: A tertiary care referral center was the setting for the study. PATIENTS: The authors present a case of a young woman with a vestibular schwannoma that enlarged 2 years after treatment with SRS. INTERVENTION: Microsurgery via the translabyrinthine approach was used.
RESULTS: At surgery, extensive scarring between the facial nerve and tumor capsule was seen, and the nerve could not be identified at all beyond several millimeters proximal to the porus acusticus. Adhesions of the tumor to the ninth and tenth cranial nerves, the brain stem, and the anterior inferior cerebellar artery were also markedly increased. Histologic examination confirmed fibrotic adhesions surrounding the facial nerve.
CONCLUSIONS: The unusual degree of fibrosis, scarring, and adhesions of the tumor to the surrounding structures after SRS made microsurgical removal of the tumor difficult and preservation of the facial nerve impossible.

Entities:  

Mesh:

Year:  1999        PMID: 10337979

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  2 in total

Review 1.  Craniopharyngioma adherence: a reappraisal of the evidence.

Authors:  Ruth Prieto; José María Pascual; Verena Hofecker; Eduard Winter; Inés Castro-Dufourny; Rodrigo Carrasco; Laura Barrios
Journal:  Neurosurg Rev       Date:  2018-07-24       Impact factor: 3.042

2.  Is salvage surgery for large vestibular schwannomas after failed gamma knife radiosurgery more challenging?

Authors:  Lucas Troude; Mohamed Boucekine; Anne Balossier; Guillaume Baucher; Jean-Pierre Lavieille; Jean Régis; Pierre-Hugues Roche
Journal:  Neurosurg Rev       Date:  2021-07-16       Impact factor: 3.042

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.